108 results
8-K
EX-10.1
khnc4jwq53tsnwe2lrx3
6 Mar 24
Vaxart, Inc. Appoints Steven Lo as New President, Chief Executive Officer, and Director
9:23am
8-K
EX-10.1
0ts 3n06j
29 Feb 24
Departure of Directors or Certain Officers
4:30pm
8-K/A
EX-10.1
thu4bxkx
2 Feb 24
Departure of Directors or Certain Officers
4:49pm
8-K
EX-10.1
evvzhrlx0l 1m
16 Jan 24
Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital Management
5:18pm
8-K
EX-3.1
9hl893x 7hyvdw
23 Oct 23
Amendments to Articles of Incorporation or Bylaws
5:01pm
8-K
EX-1.1
r0sctrux j9qm1j31x
8 Jun 23
Vaxart, Inc. Announces Proposed Public Offering of Common Stock
4:27pm
8-K
phoa9wnw jx
6 Dec 22
Vaxart Announces Collaborative Funding from Leading Foundation to Study Its Norovirus Vaccine Candidate in Breastfeeding Mothers
4:21pm
8-K/A
EX-10.1
6dlm5k1n763
5 Aug 22
Vaxart Stockholders Approve Proxy Proposals 2, 3 and 4
8:02am
8-K
nbm3e
28 Jul 22
Other Events
8:00am